What drove Calumet's 40.8% year-over-year sales growth in Q2 2026?

Calumet's 40.8% year-over-year sales growth in Q2 2026 to $1.445 billion was driven primarily by its Specialty Products and Solutions segment.

Why did Calumet report a net loss despite strong adjusted EBITDA of $159.3 million in Q2 2026?

Calumet reported a net loss in Q2 2026 due to significant noncash RIN-related expenses, even though its adjusted EBITDA increased substantially to $159.3 million.

Calumet Q2 2026 Earnings: Specialty Strength Lifts Adjusted EBITDA

Aug 8, 2026

Calumet Specialty Products Partners reported Q2 2026 sales of $1.445 billion, up 40.8% year-over-year, driven by its Specialty Products segment. Adjusted EBITDA rose to $159.3 million despite a net loss caused by RIN-related expenses.

TradingKey

2026-08-07

Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026 Results

2026-08-07

Calumet Specialty Products Partners Reports Second Quarter 2026 Results

2026-08-07

Calumet, Inc. Reports Q2 2026 Earnings Results

2026-08-08

Calumet, Inc. Reports Q2 Revenue $1.45 Billion, Surpassing Estimates

2026-08-08

Calumet Inc. Reports Q2 2026 Revenue of $1.45B, EPS ($1.09)